The high-stakes race to engineer new psychedelic drugs | Curio
News and insights read out for you.
10,000+ audio articles. 50+ world-leading publications.

All in 1 subscription.

WIRED logo

The high-stakes race to engineer new psychedelic drugs

27 mins | Aug 27, 2022
story image
Is this the start of 'Big Neuropharma'? As knowledge about the positive effects of psychedelic therapies goes mainstream, pharmaceutical companies are rushing to create patentable versions of hallucinogens. Here, John Semley questions if this is the beginning of a new era for mental health treatments or nothing more than a bad trip.
Get unlimited access free for 7 days, then $6.67/month (billed annually)
Get started